Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Metrion Biosciences launches NaV1.9 high-throughput screening assay to strengthen screening portfolio and advance research on new medicines for pain

Metrion Biosciences launches NaV1.9 high-throughput screening assay to strengthen screening portfolio and advance research on new medicines for pain

Research uncovers the cellular culprit behind age-related abdominal fat

Research uncovers the cellular culprit behind age-related abdominal fat

Researchers pioneer method to measure liver tissue stiffness without damage

Researchers pioneer method to measure liver tissue stiffness without damage

CN Bio and Pharmaron establish long-term strategic partnership to develop OOC technologies on a global R&D platform

CN Bio and Pharmaron establish long-term strategic partnership to develop OOC technologies on a global R&D platform

Mosaic Therapeutics in-licenses two clinical-stage oncology programs from Astex Pharmaceuticals for development as proprietary combination therapies

Mosaic Therapeutics in-licenses two clinical-stage oncology programs from Astex Pharmaceuticals for development as proprietary combination therapies

Scientists develop promising new drug candidates against coronaviruses

Scientists develop promising new drug candidates against coronaviruses

San Antonio scientists use machine learning to identify potential treatments for deadly viruses

San Antonio scientists use machine learning to identify potential treatments for deadly viruses

DNA origami structures enable targeted imaging of pancreatic cancer

DNA origami structures enable targeted imaging of pancreatic cancer

FDA approved anti-inflammatory drug shows promise for treating alcohol use disorder and pain

FDA approved anti-inflammatory drug shows promise for treating alcohol use disorder and pain

Boost your transfection success with these proven expert tips

Boost your transfection success with these proven expert tips

Major breakthrough could turn IV drugs into oral treatments for brain cancer and Alzheimer's

Major breakthrough could turn IV drugs into oral treatments for brain cancer and Alzheimer's

New discovery enhances cell entry for complex cancer drugs

New discovery enhances cell entry for complex cancer drugs

Researchers simulate protein structures behind learning and memory

Researchers simulate protein structures behind learning and memory

Researchers link 9 blood proteins to breast cancer and suggest 3 drugs for repurposing

Researchers link 9 blood proteins to breast cancer and suggest 3 drugs for repurposing

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Nuclera expands eProtein Discovery capabilities to enable membrane protein production

Nuclera expands eProtein Discovery capabilities to enable membrane protein production

Researchers analyze the mutational landscape of TMB-high colorectal cancer tumors

Researchers analyze the mutational landscape of TMB-high colorectal cancer tumors

New antibiotic compound emerges as strong candidate in the fight against MRSA

New antibiotic compound emerges as strong candidate in the fight against MRSA

Calibr-Skaggs receives FDA approval to test sCAR-T therapy in patients with autoimmune diseases

Calibr-Skaggs receives FDA approval to test sCAR-T therapy in patients with autoimmune diseases

Advancing Adherent Cell Assays with SemaCyte® Technology

Advancing Adherent Cell Assays with SemaCyte® Technology

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.